Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
|Videos|September 10, 2017
How Do Officials Test if Drugs Are Counterfeit or Not?
Author(s)Contagion® Editorial Staff
Milena McLaughlin, PharmD, MSc, explains how officials test if a drug is counterfeit or active.
Advertisement
Milena McLaughlin, PharmD, MSc, Assistant Professor, Pharmacy Practice, Midwestern University and Northwestern Memorial Hospital, explains how officials test if a drug is counterfeit or active.
Interview Transcript (slightly modified for readability):
“They’ll take a tablet and break it in half and actually rub it across [a] card, and then put that in water, and they can actually see, based on a reaction and the colors that come up on the card, if it’s actually an active medication or not. And so, that can tell them if there’s an active drug in the tablet. However, it can’t tell them how much active drug is in the tablet, so they’re also working on seeing quantitatively how much drug is in there as well.”
Advertisement
Related to this article
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
Gavin Harris, MD, provides some context around what is happening in the Democratic Republic of Congo regarding the outbreak including the country’s inherent challenges as well as discussing the latest in testing, vaccines, and treatments of this rare strain of Ebola.
Advertisement
Advertisement